![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_ebac36f7213da3162d29205ab4152aca.svg) | Prazosin | IC50 | 0.88 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_fe0752a8b8d7dcc41cb04f6c3cbe759b.svg) | Tamsulosin | IC50 | 1.4 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_628cf5c819819c75fc97c108403b82dd.svg) | Methyl 5-[3-(4,4-diphenylpiperidin-1-yl)propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 1047.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_a48ee907e46c34256bd466f58a4afd5c.svg) | Cyclazosin | Ki | 0.17 [1], 3.24 [2], 31.62 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_b46a2577496f41af96e22052685ef08f.svg) | 3-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 0.36 [1], 2.75e+18 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_5f6b1128b3253286953ce0b4d920043e.svg) | N-((1r,4r)-4-(4-(2-Cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide | Ki | 2.0 [1], 34.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_d64ff67e90175d413c9f5dcf3016be21.svg) | N-((1r,4r)-4-(4-(2-Isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide | Ki | 0.77 [1], 1.7 [2], 40.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_7144d123238b854bbde00080619e7f09.svg) | 3,4-Dimethoxy-N-[4-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperidin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 2.2 [1], 23.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_f9039ce6bbf46370f0f0b0f9596f9c5e.svg) | N-((1r,4r)-4-(4-(2-(2-Fluoroethoxy)phenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide | Ki | 5.5 [1], 8.8 [2], 49.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_f8f80c78dd47ec14086988730d776a2f.svg) | N-[4-[4-[2-(2,2-Difluoroethoxy)phenyl]piperidin-1-yl]cyclohexyl]-3,4-dimethoxybenzenesulfonamide | Ki | 4.1 [1], 8.6 [2], 86.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_25c5cb3558564838a1f2f6cd6a2ee4af.svg) | 3,4-Dimethoxy-N-[4-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 0.68 [1], 1.0 [2], 24.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_e684ff905325760b5d18575644f1108f.svg) | Phentolamine | Ki | 7.6 [1], 11.0 [2], 19.4 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_100a6b13486c9975a61ba5f10cb38eb9.svg) | Yohimbine | Ki | 1.6 [1], 289.0 [2], 498.0 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_2f8b1a65fcaa2c2002b0eddc770532aa.svg) | Silodosin | IC50 | 6.3 [1], 27.3 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_2f8b1a65fcaa2c2002b0eddc770532aa.svg) | Silodosin | Ki | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_61b54f6a9d8fde0cb2e300ef5abb08c9.svg) | Naftopidil | IC50 | 55.2 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_61b54f6a9d8fde0cb2e300ef5abb08c9.svg) | Naftopidil | Ki | 1.2 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_09d61e0b7585577e0b350506f4f4c16d.svg) | 8-(2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl)-8-azaspiro[4.5]decane-7,9-dione dihydrochloride | Ki | 1.05 [1], 1.29 [2], 6.31 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_aaf0c948ec6905346ef46a5321d52fb9.svg) | 7-Chloro-2-ethenyl-3,4,5,6-tetrahydro-4-methylthieno(4,3,2-ef)(3)benzazepine | Ki | 1.6 [1], 3.16 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_0b339e2acee573672438af836b0b3fe7.svg) | Methyl 1-[3-[[5-carbamoyl-4-(3,4-difluorophenyl)-6-ethyl-2-oxo-1,4-dihydropyrimidine-3-carbonyl]amino]propyl]-4-phenylpiperidine-4-carboxylate | Ki | 340.0 [1], 350.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_da3a4948f404fa572f0ac6e028f676fa.svg) | (4S,5S)-4-(3,4-Difluorophenyl)-N-[3-[4-(4-fluorophenyl)piperidin-1-yl]propyl]-5-methyl-2-oxo-1,3-oxazolidine-3-carboxamide | Ki | 122.0 [1], 133.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_ab1ab4ef07b41b9f04486287fd7265b9.svg) | 8-[(2R)-1-[4-(2,4,5-Trifluorophenyl)piperazin-1-yl]propan-2-yl]-8-azaspiro[4.5]decane-7,9-dione | Ki | 1.3 [1], 1.6 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_4453feaaab4157d3691abc3d53b4a76c.svg) | N-[[(3S)-2,3-Dihydro-1,4-benzodioxin-3-yl]methyl]-2-(2,6-dimethoxyphenoxy)ethanamine;hydrochloride | Ki | 0.51 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_f55cc3c3d081e9b01c9a5590a44a3b44.svg) | 5-N-[3-(4,4-Diphenylpiperidin-1-yl)propyl]-3-N,2,6-trimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 616.0 [1], 616.6 [2], 758.58 [3] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_b9c45eb2042fa8caa502ce4b5f696301.svg) | N-[(2,2-Diphenyl-1,3-dioxolan-4-yl)methyl]-2-phenoxyethanamine;oxalic acid | Ki | 11.48 [1], 11.75 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_822ed9ddbb0a07c5a21db2f3d121f745.svg) | Rauwolscine | Ki | 3.5 [1], 1320.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_6bd8428f24df55bebd5446ef40e0614c.svg) | Brimonidine | Ki | 846.0 [1], 933.25 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_ea0f5584ab0c621398ec482f268c656f.svg) | Oxymetazoline | Ki | 1348.96 [1], 1398.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_be653f89bf9757f77ea6b06dba105b92.svg) | Alfuzosin | Ki | 3.16 [1], 3.6 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_01e12972ea4730f06a2b9903f3170d50.svg) | Indoramin | Ki | 110.0 [1], 158.49 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_dbc04cc2bb288e3684ed846b2d98ba3b.svg) | 5-Methylurapidil | Ki | 10.0 [1], 21.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_45dcbd1bf64013c2b1cc683f9b147e16.svg) | Niguldipine | Ki | 100.0 [1], 191.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_a5f6b839e0f27ed6fd77b5892e78922f.svg) | Dexniguldipine | Ki | 100.0 [1], 170.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_1fda4985931c2c480c4e88e39e59e589.svg) | Upidosin | Ki | 1.5 [1], 2.51 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_7e67dc53b9dda9b460fb3afbfa5076d7.svg) | N,N-Diallyl-5-methoxytryptamine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_aa92cb575f0456161594c002e3244813.svg) | CID 9872515 | Ki | 63.1 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_a0b09fab2d611112d3464cc7ebe53846.svg) | 2-(2-Biphenylyloxymethyl)-2-imidazoline | IC50 | 323.59 [1], 549.54 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_6fb29d61b659d85f4cfb55da06cb24ed.svg) | N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2-(2-phenylmethoxyphenoxy)ethanamine | Ki | 0.07 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_09496d3520391d098ba91bc7bd71681d.svg) | Methyl 4-(3,4-difluorophenyl)-3-[3-(4-methoxycarbonyl-4-phenylpiperidin-1-yl)propylcarbamoyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-5-carboxylate | Ki | 140.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_08c0971c1869066381e936848545bc75.svg) | 2-(2,6-Dimethoxyphenoxy)-N-[[(2R)-6,6-diphenyl-1,4-dioxan-2-yl]methyl]ethanamine | Ki | 56.23 [1], 66.07 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_a046fe66477fb00d53548d3fc5f8d779.svg) | N-[[(2R)-6,6-Diphenyl-1,4-dioxan-2-yl]methyl]-2-(2-methoxyphenoxy)ethanamine | Ki | 1.15 [1], 1.38 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_578f6b3954dcdeb8c030d8c880a5d0e8.svg) | N-[[(2R)-6,6-Diphenyl-1,4-dioxan-2-yl]methyl]-2-phenoxyethanamine | Ki | 3.24 [1], 3.63 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_3f9f85b39a39a1d6cb0eeb1e9970d8e1.svg) | 5-N-[4-(4,4-Diphenylpiperidin-1-yl)butyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 398.0 [1], 398.11 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_8342c3aea2030e0fc19ccbf45b947886.svg) | N-[[(3R)-2,3-Dihydro-1,4-benzodioxin-3-yl]methyl]-2-(2,6-dimethoxyphenoxy)ethanamine;hydrochloride | Ki | 10.47 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_353de4856aad482e432e828dd0efa8b5.svg) | 5-N-[3-(4,4-Diphenylpiperidin-1-yl)propyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxamide | Ki | 346.0 [1], 602.56 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_b375adc21a71cbe0cd48b1b84c9c7bed.svg) | 3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-1H-[1]benzothiolo[3,2-d]pyrimidine-2,4-dione | Ki | 1.26 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_176d1a3872da10db969250d52fdcd866.svg) | Methyl 1-[3-[[5-carbamoyl-4-(2,4-difluorophenyl)-6-ethyl-2-oxo-1,4-dihydropyrimidine-3-carbonyl]amino]propyl]-4-phenylpiperidine-4-carboxylate | Ki | 340.0 [1], 440.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_0fbf0b4199855e630345b0acb4e62361.svg) | Methyl 4-(3,4-difluorophenyl)-3-[5-(4-methoxycarbonyl-4-phenylpiperidin-1-yl)pentyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-5-carboxylate | Ki | 150.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_d14bb93839d4d29e6d80a2e4086dd705.svg) | Methyl 5-[4-(4,4-diphenylpiperidin-1-yl)butylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | Ki | 144.54 [1], 331.13 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_9f808a379db3d869fc1b4206e253e9e5.svg) | 3-[2-[4-(4-Propan-2-ylphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 35.48 [1], 2.82e+16 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_afefbe985782743dd5bece6ebe5ef62e.svg) | 3-[2-[4-(4-Butan-2-ylphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 60.26 [1], 1.66e+16 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_19300747df82e7b0e5af209b6c869de1.svg) | 3-[2-[4-(4-Butylphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 245.47 [1], 4073800000000000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_13ca4eb6133cbcc6a9565cb6a5cb5c73.svg) | 3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-2-methyl-5H-pyrimido[5,4-b]indol-4-one | Ki | 0.41 [1], 2.45e+18 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_7bc331b6d9834a42e9a23e5e2893c137.svg) | 3-[2-[4-(4-Tert-butylphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 19.95 [1], 5.01e+16 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_b2d5c4d3b4ae880e24b60fc6997f2a83.svg) | 5-Chloro-2-methoxy-N-[4-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 0.75 [1], 11.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_ab55beb69b4af1c1d0519688b194945f.svg) | 1-[3-(Di-p-tolylacetylamino)propyl]-4-phenylpiperidine-4-carbonitrile | Ki | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_44dda55113f8657f04793721a48de0ff.svg) | N-[(6,6-Diphenyl-1,4-dioxan-2-yl)methyl]-2-(2-methoxyphenoxy)ethanamine | Ki | 1.15 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_598fcce9dc0151b23668cb40b023cc0b.svg) | 1-(1,4-Dioxaspiro[4.5]decan-3-ylmethyl)-4-(2-methoxyphenyl)piperazine | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_a218b274b90e6950b6059091208950fd.svg) | 1-[3-(Di-p-tolylacetylamino)propyl]-4-phenylpiperidine-4-carboxylic acid methyl ester | Ki | 960.0 [1], 975.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_20a5f9e5686a3c7bb7b08df712d78637.svg) | 1-[3-(4-Methylphenylacetylamino)propyl]-4-phenyl-4-piperidinecarboxylic acid methyl ester | Ki | 3400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_115e36c2ce2881e19a58beabd8edad98.svg) | 3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-2-methyl-[1]benzothiolo[3,2-d]pyrimidin-4-one | Ki | 0.4 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_c4d9a3069d676004683f1effc26cf957.svg) | N-((1r,4r)-4-(4-(2-Isopropoxyphenyl)piperazin-1-yl)cyclohexyl)-4-(methylsulfonyl)benzenesulfonamide | Ki | 3.4 [1], 22.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_5b9ba8637a208e1f7ea1090009f0036d.svg) | 2-Methoxy-5-methyl-N-[4-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 7.0 [1], 31.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_3554202f0fb3610b105ba24dab0acab3.svg) | 5-Fluoro-2-methoxy-N-[4-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 5.0 [1], 66.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_f956c5c96589c75da105cb3dc85948d0.svg) | 2,4-Dichloro-N-[4-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 0.64 [1], 8.6 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_2a34c290cca361110b84839193106547.svg) | [(4Ar,8aS)-4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-2,3,4a,5,6,7,8,8a-octahydroquinoxalin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone | Ki | 0.17 [1], 3.89 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_a758e6a140a27a18d8984ea19745dfc6.svg) | N-[(2,2-Diphenyl-1,3-dioxolan-4-yl)methyl]-2-(2-methoxyphenoxy)ethanamine;oxalic acid | Ki | 9.33 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_e05caad144627d9574fb9fa6d680a565.svg) | N-[[(3S)-2,3-Dihydro-1,4-benzodioxin-3-yl]methyl]-2-(2-methoxynaphthalen-1-yl)oxyethanamine;hydrochloride | Ki | 6.61 [1] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_76f6b46406248b58e405df5cd3aa5ab7.svg) | 1-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]-4-phenylpiperidine-2,6-dione | Ki | 2.0 [1], 15.85 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_7b6e651dd1176da56cf46d87f01bfbda.svg) | 5-Methyl-1,5-diazapentacyclo[10.8.1.02,7.08,21.013,18]henicosa-2(7),8(21),9,11,13,15,17-heptaene | Ki | 293.0 [1], 295.12 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_6a047b6da196d2977939f018472f9739.svg) | [(4As,8aR)-4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-2,3,4a,5,6,7,8,8a-octahydroquinoxalin-1-yl]-(furan-2-yl)methanone | Ki | 0.06 [1], 3.24 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_6c7c1bedd3a0bcaf7b8527fe16c330ea.svg) | 5-O-[3-(4,4-Diphenylpiperidin-1-yl)propyl] 3-O-methyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | Ki | 210.0 [1], 302.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_a404d46b8b04d9b150e8d5a4c6c996f3.svg) | N,N'-Bis(8-methylquinolin-4-yl)ethane-1,2-diamine | Ki | 478.63 [1], 479.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_e036d9e4779f8c3aa4272ce29893d0aa.svg) | Methyl 4-(3,4-difluorophenyl)-3-[5-(4,4-diphenylpiperidin-1-yl)pentyl]-2,6-dimethyl-4H-pyrimidine-5-carboxylate | Ki | 110.0 [1], 180.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_0cc5cd18a682bff291e7e89ee61b6676.svg) | 3,4-Dimethoxy-N-[4-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 0.35 [1], 8.3 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_fa84e3d527e241f60ea04a9ad0e870ad.svg) | 3,4-Difluoro-N-((1r,4r)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)benzenesulfonamide | Ki | 7.3 [1], 87.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_5b5f132f4ca9dff545a2c94dcc2745ca.svg) | 5-Chloro-N-[4-[4-(2-cyclopropyloxyphenyl)piperidin-1-yl]cyclohexyl]-2-methoxybenzenesulfonamide | Ki | 2.6 [1], 47.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_cf5d538ed40de03556dd81efef815cb0.svg) | 5-Chloro-N-((1r,4r)-4-(4-(2-cyclopropoxyphenyl)piperidin-1-yl)cyclohexyl)-2-fluorobenzenesulfonamide | Ki | 2.1 [1], 32.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_ed226f0b27c0dff4fb86d3f972e7acbf.svg) | N-[4-[4-[2-(2,2,2-Trifluoroethoxy)phenyl]piperidin-1-yl]cyclohexyl]-2,3-dihydro-1,4-benzodioxine-6-sulfonamide | Ki | 3.0 [1], 26.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_6fba41aaeca333dba7f3ccf65f54fd60.svg) | 5-Chloro-2-methoxy-N-[4-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperidin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 1.6 [1], 36.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_7eb12affdac7e222777b084793a9e16d.svg) | 5-Chloro-2-fluoro-N-[4-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperidin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 0.98 [1], 44.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_8fd7f4f186e05e114edbfad01d362767.svg) | 3-(Difluoromethoxy)-N-[4-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperidin-1-yl]cyclohexyl]benzenesulfonamide | Ki | 5.9 [1], 70.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_dddb215331172649720e42adbb10c75c.svg) | N-[4-[4-(4-Fluoro-2-propan-2-yloxyphenyl)piperidin-1-yl]cyclohexyl]-3,4-dimethoxybenzenesulfonamide | Ki | 12.0 [1], 60.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_5f84ebffb44fb9e5189f06433983687b.svg) | N-[4-[4-(5-Fluoro-2-propan-2-yloxyphenyl)piperidin-1-yl]cyclohexyl]-3,4-dimethoxybenzenesulfonamide | Ki | 1.6 [1], 53.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_4de98aad55a49a008cbe48d447b0b8aa.svg) | N,N'-Bis(6-methylquinolin-4-yl)ethane-1,2-diamine | Ki | 489.78 [1], 490.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_cf76fbaffe5d3a03ce1e1c7915b30d0b.svg) | N,N'-Bis(7-methylquinolin-4-yl)ethane-1,2-diamine | Ki | 204.0 [1], 204.17 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_6910c346517e95faec34ae2c3065c5e9.svg) | N,N'-Bis(7-methoxyquinolin-4-yl)ethane-1,2-diamine | Ki | 213.8 [1], 214.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_6ecab37e2267b7ead7ee495039d398cb.svg) | N,N'-Bis(6-methylquinolin-4-yl)heptane-1,7-diamine | Ki | 478.63 [1], 479.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_47a8b86c1a0274396019f8bbd8b3320f.svg) | N,N'-Bis(6-methoxyquinolin-4-yl)heptane-1,7-diamine | Ki | 371.54 [1], 372.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_4008ae71438615441828fde72c951598.svg) | N,N'-Bis(7-methylquinolin-4-yl)heptane-1,7-diamine | Ki | 489.78 [1], 490.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_3e4911c673683a042f54d0943158c1f1.svg) | N,N'-Bis(7-methoxyquinolin-4-yl)heptane-1,7-diamine | Ki | 229.0 [1], 229.09 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_f6c238583229af17f25bc872a3c15a10.svg) | N,N'-Bis(8-methoxyquinolin-4-yl)heptane-1,7-diamine | Ki | 758.58 [1], 759.0 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_6ed8a960bedaa3ad6ed50707c8c6afbb.svg) | 1,7-Heptanediamine, N,N'-di-4-quinolinyl- | Ki | 309.0 [1], 309.03 [2] |
![](https://images.aatbio.com/dataset/ic50/alpha-1d-adrenergic-receptor_11da3107f9e8310ed47c0c811b8a33d9.svg) | 1,2-Ethanediamine, N,N-di-4-quinolinyl- | Ki | 331.0 [1], 331.13 [2] |